Rigel Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -20.2% | +19.5% | +0.0% | -74.9% | +298.2% | -100.0% | – | +172.2% | +678.2% | -66.7% | -17.6% | +100.4% | -26.2% | +262.1% | -71.3% | +14.8% | +0.3% | +339.1% | -67.6% | -18.0% | -5.3% | -18.0% | +78.2% | -24.8% | +128.8% | -49.2% | +3.1% | +4.6% | +27.2% | -17.5% | +24.7% | +50.1% | +4.1% | -7.4% | +90.7% | -31.7% | +0.5% | -15.7% | +33.8% | – | |
| – | -28.1% | +6.4% | -6.9% | -6.2% | +7.0% | -2.8% | -99.7% | +130.0% | +172.5% | -43.1% | +190.7% | -0.3% | -42.6% | -12.9% | +80.0% | -49.8% | +129.3% | -1.6% | -59.2% | +17.1% | +222.5% | -75.2% | +756.2% | -75.9% | +36.8% | +185.7% | +10.0% | +18.0% | +198.9% | -46.6% | +38.6% | +185.9% | -27.9% | -23.8% | +2.2% | +5.5% | +25.3% | -22.7% | +85.1% | – | |
| – | – | – | – | – | – | – | – | +173.0% | +685.4% | -66.8% | -19.3% | +103.5% | -25.9% | +265.3% | -71.7% | +15.9% | -0.7% | +345.2% | -67.6% | -18.2% | -6.9% | -16.6% | +73.2% | -23.0% | +129.9% | -50.7% | +2.9% | +4.1% | +19.1% | -14.0% | +23.7% | +38.9% | +9.6% | -5.6% | +98.6% | -33.4% | -1.3% | -15.1% | +29.5% | – | |
| – | -28.1% | +6.4% | -6.9% | -6.2% | +7.0% | -2.8% | -4.0% | +2.8% | +24.1% | -20.5% | +20.8% | +9.4% | -1.5% | +13.4% | -12.0% | +2.7% | +3.7% | +11.2% | -0.1% | +8.9% | -27.3% | +16.3% | -4.6% | -0.7% | +4.8% | -34.3% | -52.7% | +35.7% | -50.8% | +89.1% | -8.1% | +11.6% | -8.9% | +49.8% | -19.1% | +7.8% | +45.3% | +9.3% | +19.6% | – | |
| – | +56.9% | +3.6% | +5.5% | +1.6% | +84.4% | -7.9% | +26.5% | +5.8% | +18.3% | -6.7% | -8.7% | -0.5% | +1.1% | +0.6% | +2.7% | -7.9% | +5.7% | +18.4% | +2.6% | +2.2% | +7.2% | +11.8% | -1.5% | -4.0% | +24.2% | -13.8% | -5.1% | -5.5% | +5.8% | +8.1% | -1.4% | -3.6% | +9.2% | -6.1% | +5.6% | -1.1% | +3.6% | +2.2% | +6.5% | – | |
| – | -9.4% | +5.3% | -2.2% | -3.0% | +39.8% | -5.6% | +12.7% | +4.7% | +20.5% | -12.1% | +1.7% | +3.7% | -0.1% | +6.2% | -4.2% | -3.3% | +15.4% | +5.4% | +0.6% | +5.1% | +0.4% | +3.7% | -2.6% | -2.8% | +20.4% | -22.6% | -17.8% | +0.8% | -4.1% | +14.8% | -2.6% | -1.1% | +5.8% | +2.8% | -0.2% | +0.6% | +12.1% | +4.1% | +10.1% | – | |
| – | – | – | – | – | – | – | – | – | – | -825.8% | – | – | – | – | -182.7% | – | – | – | -131.2% | – | – | – | – | – | – | -712.1% | – | – | – | -454.3% | – | +3,044.5% | +18.5% | -23.3% | +378.4% | -53.5% | -18.5% | -48.7% | +98.4% | – | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +3,987.5% | -56.6% | +148.6% | +21.5% | +0.0% | +13.1% | +262.7% | -25.1% | -1.4% | -7.2% | -52.8% | +45.2% | +34.0% | +8.8% | +54.7% | +2.0% | +0.4% | -1.7% | +8.3% | +1.5% | -5.1% | -5.2% | +1.1% | +1.1% | -10.3% | -15.7% | -45.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -645.2% | – | – | – | – | -182.7% | – | – | – | -135.8% | – | – | – | – | – | – | -1,066.2% | – | – | – | -1,219.0% | – | – | +22.6% | -24.4% | +421.1% | -54.0% | -17.8% | -48.7% | +102.3% | – | |
| – | -106.0% | – | – | – | – | – | – | – | – | – | – | – | -48.8% | +26.1% | -52.8% | -78.7% | -619.4% | – | -154.8% | – | – | – | -55.5% | +20.3% | +6.9% | +19.6% | -71.3% | +188.4% | +0.9% | -47.4% | – | – | – | -92.6% | +467.7% | -175.9% | – | – | +109.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -645.2% | – | – | – | – | -182.7% | – | – | – | -135.0% | – | – | – | – | – | – | -1,066.2% | – | – | – | -1,219.0% | – | – | +15.5% | -20.2% | +420.8% | -53.2% | +860.8% | -96.8% | +99.8% | – | |
| – | – | – | – | – | – | – | – | – | – | -746.9% | – | – | – | – | -179.1% | – | – | – | -130.4% | – | – | – | – | – | – | -528.9% | – | – | – | -303.4% | – | +836.2% | +17.8% | -21.4% | +347.2% | -51.8% | -16.9% | -45.3% | +84.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.